This investigation of female carriers of progressive muscular dystrophy was prompted by the observation of an enlarged calf in the 34-year-old mother (Case 1) of one of my patients. On questioning she thought that her left calf had been enlarged since she was 13 years old. She had sometimes experienced cramps in that calf on exertion. Although there was no clinical evidence of any muscle weakness, this prominence of the calf resembled the 'pseudohypertrophy' of muscular dystrophy and the possibility of a subclinical involvement of the muscle seemed feasible. This was of particular interest in view of recent reports of slightly raised levels of creatine phosphokinase in the serum ofsome carriers (Schapira et al. 1960 , Aebi et al. 1961 , Hughes 1962 .
Muscle biopsy from the medial head of her left gastrocnemius showed extensive histological changes (Fig 1) . The fibres varied considerably in size and shape. Many were abnormally large and between 80 and 140,u in diameter. Others were atrophic and less than 20p. in diameter.
There was also evidence of hyaline degeneration and phagocytosis in a number of fibres. The sarcolemmal nuclei were prominent and increased in number (8-10 per transverse section). Some fibres had internal nuclei. There was also some proliferation of the endomysial and perimysial connective tissue especially in relation to atrophic fibres. These changes were considered to be outside the range of normal and consistent with a myopathic involvement. A detailed report of this case appears elsewhere (Dubowitz 1963) .
In view of these findings it was thought worth investigating further known carriers who were clinically symptom free.
Biopsy studies of the gastrocnemius were carried out in twin sisters who were known carriers of progressive muscular dystrophy of the Duchenne type (Fig 2: II, 4 and II, 5). Blood group studies confirmed that they were identical twins. Each had an affected son. Neither of these women had any symptoms and on clinical examination there was no abnormality. The calves were not prominent.
In both biopsies there were abnormal histological changes. In the first twin, Case 2, the fibre diameter varied from 30 to 130p. There was an increase in sarcolemmal nuclei and in longitudinal section these tended to occur in chains (Fig 3) . There were also focal areas of degeneration and phagocytosis. The endomysial connective tissue was not increased in amount but showed increased cellularity. The second twin, Case 3, showed similar but somewhat more marked changes (Fig 4) . The fibres tended to be rounded rather than polygonal in cross sections. Most fibres were between 50 and 1 10, in diameter but some reached 160p. There were also a few fibres less than 50i in diameter. There was an increase in sarcolemmal nuclei and many fibres also contained internal nuclei. Some fibres showed wellmarked longitudinal splitting. There was an increase in endomysial connective tissue particularly in relation to atrophic fibres (Fig 5) .
A fourth case biopsied was a woman of 39 with three affected sons, and two clinically healthy daughters. The muscle was practically within normal limits. However, the fibre size ranged from 30 to 1IOp and there were isolated fibres undergoing degeneration or phagocytosis.
Serum creatine phosphokinase levels were estimated in these patients by Dr B P Hughes.
The results were as follows: Case 1, 20 units; 
Discussion
The histological changes in the muscle of these carriers are of particular interest because they fulfil Erb's criteria of myopathy (Erb 1891) , and suggest that female carriers of the sex-linked recessive Duchenne type of muscular dystrophy do have subclinical involvement ofthe muscle.
-One of the difficulties in interpreting minimal pathological changes in muscle is to know what are the limits of normal. One may see occasional foci of cellularity in normal muscles and, particularly in specimens from elderly patients, I have observed extensive degenerative changes of muscle fibres. However, the muscle fibres under these circumstances are not enlarged and usually range from about 25 to 75p in diameter.
The presence of pathological changes in the muscle of clinically normal carriers could ex-plain the raised levels of creatine kinase in the serum. The enzyme leaks out from the damaged muscle. Variation in enzyme levels in the serum may reflect a difference in extent of muscle involvement.
It thus seems that the symptom-free carriers of the sex-linked muscular dystrophy may have minimal pathological involvement comparable to that seen in some of the sex-linked bleeding disorders. It will be of interest, when the fundamental biochemical lesion in progressive muscular dystrophy is discovered, to see whether the female carrier shows any abnormality.
The following paper was also read: 
